CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 ...
Phase 3
Montreal, Quebec, Canada and 18 other locations
Diabetes is one of the biggest public health challenges of the 21st century because of the costs associated with its management, which are e...
Saint-Mathieu, Quebec, Canada
A randomized controlled trial (RCT) to assess the safety and efficacy of use of Control-IQ technology in adults with type 2 diabetes using b...
Montréal, Quebec, Canada and 20 other locations
This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing ...
Phase 4
Montreal, Quebec, Canada and 88 other locations
drug in the treatment of adult participants with a diagnosis of Diabetic Kidney Disease due to either Type 1 diabetes mellitus or T...
Phase 2
Laval, Quebec, Canada and 71 other locations
This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...
Phase 3
Saint-Laurent, Quebec, Canada and 173 other locations
The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...
Phase 3
Montreal, Quebec, Canada and 636 other locations
The aim of this study is to test the hypothesis that the effects on albuminuria of combination treatment with the endothelin receptor antagonist zibo...
Phase 2
Montreal, Quebec, Canada and 6 other locations
The purpose of the study is to evaluate the safety and tolerability of ENC-201-CED in a subcutaneous space in patients with Type I diabetes....
Phase 1
Montréal, Quebec, Canada
This study will evaluate the safety, tolerability and efficacy of VX-880 infusion in participants with Type 1 diabetes mellitus (T1D) and im...
Phase 1, Phase 2
Montreal, Canada and 21 other locations
Clinical trials
Research sites
Resources
Legal